The ExCEEd Orphan announces its cooperation with Pharming in commercialization of RUCONEST® (conestat alfa) in selected countries of the CEE region. ExCEEd Orphan will primarly focus on countries like Albania, Croatia, Hungary, North Macedonia, Romania, Serbia and Slovenia to build awarennes in the treatment of angioedema attacks in patients with hereditary angioedema (HAE).
ExCEEd Orphan is proud to be involved in bringing such unique therapy to patients who suffer from rare genetic condition from HAE.